From San Diego, at a meeting of the American Society of Hematology
A novel drug appears to help people with myelodysplasia, a persistent condition that leaves them short of crucial blood components. The drug could become the first treatment specifically for the condition, says Alan List of the University of South Florida in Tampa.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.